AMPHENOL CORP /DE/ Quarterly Cost of Revenue in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Amphenol Corp /De/ quarterly/annual Cost of Revenue history and growth rate from Q1 2017 to Q3 2024.
  • Amphenol Corp /De/ Cost of Revenue for the quarter ending September 30, 2024 was $2.68B, a 24.7% increase year-over-year.
  • Amphenol Corp /De/ Cost of Revenue for the twelve months ending September 30, 2024 was $9.47B, a 12.2% increase year-over-year.
  • Amphenol Corp /De/ annual Cost of Revenue for 2023 was $8.47B, a 1.45% decline from 2022.
  • Amphenol Corp /De/ annual Cost of Revenue for 2022 was $8.59B, a 15% increase from 2021.
  • Amphenol Corp /De/ annual Cost of Revenue for 2021 was $7.47B, a 25.9% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.47B $2.68B +$531M +24.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q2 2024 $8.94B $2.4B +$334M +16.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $8.61B $2.17B +$137M +6.73% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $8.47B $2.23B +$25.4M +1.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $8.45B $2.15B -$84.5M -3.78% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q2 2023 $8.53B $2.06B -$70.4M -3.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $8.6B $2.03B +$5.3M +0.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $8.59B $2.2B +$116M +5.57% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $8.48B $2.24B +$307M +15.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $8.17B $2.13B +$322M +17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $7.85B $2.03B +$376M +22.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $7.47B $2.09B +$425M +25.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $7.05B $1.93B +$340M +21.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $6.71B $1.81B +$427M +30.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $6.28B $1.65B +$347M +26.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $5.93B $1.66B +$188M +12.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 $5.75B $1.59B +$150M +10.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $5.6B $1.38B +$16M +1.17% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $5.58B $1.3B -$28.5M -2.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $5.61B $1.47B -$37.4M -2.48% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $5.65B $1.44B -$2.1M -0.15% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $5.65B $1.37B +$31.1M +2.33% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $5.62B $1.33B +$70.7M +5.61% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 $5.55B $1.51B +$201M +15.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 $5.35B $1.44B +$206M +16.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $5.14B $1.34B +$223M +20% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $4.92B $1.26B +$216M +20.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q4 2017 $4.7B $1.31B Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $1.23B Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $1.11B Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $1.04B Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.